Développement de membranes fonctionnalisées et nanostructurées, constituées de facteurs de croissance et de cellules souches mésenchymateuses, à des fins de thérapies cartilagineuses en chirurgie de la main
Sybille Facca(Inserm), Philippe Liverneaux(Hôpitaux Universitaires de Strasbourg), C. Palomares-Mendoza(Inserm), Florence Fioretti(Inserm), Audrey Ferrand(Université Toulouse III - Paul Sabatier), Nadia Benkirane-Jessel(Inserm)
Cited by 0
Related Papers
Epidermal Growth Factor Receptor Mutants from Human Lung Cancers Exhibit Enhanced Catalytic Activity and Increased Sensitivity to Gefitinib
|Cancer Research|2007|192
Characterization of Human Colon Organoids From Inflammatory Bowel Disease Patients
|Frontiers in Cell and Developmental Biology|2020|154
Prognostic implication of FLT3 and Ras gene mutations in patients with acute promyelocytic leukemia (APL): a retrospective study from the European APL Group
|Leukemia|2005|139
Gastrin and cancer: A review
|Cancer Letters|2005|119
Critical Role of Src and SHP-2 in sst2 Somatostatin Receptor-mediated Activation of SHP-1 and Inhibition of Cell Proliferation
|Molecular Biology of the Cell|2003|84